METHOD OF FORMING COMPLEX
    4.
    发明公开
    METHOD OF FORMING COMPLEX 审中-公开
    法形成的复合物

    公开(公告)号:EP1319710A4

    公开(公告)日:2005-02-09

    申请号:EP01965691

    申请日:2001-09-18

    申请人: TAKARA BIO INC

    IPC分类号: C12N15/09 C12Q1/68

    摘要: A method of forming a complex consisting of a double-stranded nucleic acid and oligonucleotide(s) characterized by comprising: the step of mixing a double-stranded nucleic acid with at least one oligonucleotide to give a reaction mixture, wherein the oligonucleotide is a chimeric oligonucleotide containing at least a member selected from among deoxyribonucleotides and nucleotide analogs and a ribonucleotide and having a sequence substantially complementary to the base sequence of one of the strands of the double-stranded nucleic acid as described above; and the step of incubating the reaction mixture to form a complex under such conditions that the above-described double-stranded nucleic acid is not denatured.

    THERAPEUTIC AGENTS
    10.
    发明公开
    THERAPEUTIC AGENTS 有权
    治疗WIRKSTOFFE

    公开(公告)号:EP1086952A4

    公开(公告)日:2005-02-02

    申请号:EP99923961

    申请日:1999-06-08

    申请人: TAKARA BIO INC

    摘要: Therapeutic or preventive agents for diseases requiring apoptosis induction, cancerous diseases, diseases requiring the inhibition of active oxygen production, those requiring the inhibition of nitrogen monoxide production, those requiring the inhibition of prostaglandin synthesis, those requiring the inhibition of synovial cell proliferation, those requiring the induction of heat shock protein production or those requiring the inhibition of α-glycosidase, which contain as the active ingredient compounds selected from among compounds represented by general formula (I), (wherein X and Y are each H or CH2OH, provided that when X is CH2OH, Y is H, while when X is H, Y is CH2OH), those represented by general formula (II), (wherein R is a residue obtained by freeing a compound having an SH group from the SH group) and salts of both; and foods, drinks, cosmetics and so on, containing compounds selected from among compounds of general formula (I), those of general formula (II) and salts of both.

    摘要翻译: 需要凋亡诱导的疾病的治疗或预防剂,癌性疾病,需要抑制活性氧产生的疾病,需要抑制一氧化氮产生的那些,需要抑制前列腺素合成的那些,需要抑制滑膜细胞增殖的那些 ,需要诱导热休克蛋白产生的那些或需要抑制α-糖苷酶的那些,其含有选自通式(I)表示的化合物中的活性成分的化合物(其中X和Y各自为H或CH 2 OH, 条件是当X是CH 2 OH时,Y是H,而当X是H时,Y是CH 2 OH),由通式(II)表示的那些,其中R是从SH基团中释放具有SH基团的化合物获得的残基 )和两者的盐; 和食品,饮料,化妆品等,含有选自通式(I)的化合物,通式(II)的化合物和二者的盐的化合物。